Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: Human F-actin and DNA as targets for therapy

Journal of Medical Microbiology

Volumn 58, Issue 4, 2009, Pages 492-502

  Parks, Quinn M ^a   Young, Robert L ^b   Poch, Katie R ^a   Malcolm, Kenneth C ^a   Vasil, Michael L ^c   Nick, Jerry A ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; DNA; F ACTIN; ISOSORBIDE DINITRATE; POLYAMINOACID; POLYASPARTIC ACID; ACTIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; PEPTIDE; TOBRAMYCIN;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DRUG POTENTIATION; GENE TARGETING; HUMAN; INOCULATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REACTOR; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ACTINS; ANTI-BACTERIAL AGENTS; BIOFILMS; CIPROFLOXACIN; DEOXYRIBONUCLEASES; DNA; HUMANS; NEUTROPHILS; PEPTIDES; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 65649093014     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.005728-0     Document Type: Article

References (41)

1. Balfour-Lynn, I. M. (1999). The protease-antiprotease battle in the cystic fibrosis lung. J R Soc Med 92 (Suppl. 37), 23-30. (Pubitemid 29213853)
2. Baumgartner, A. & Grand, M. (2006). Bacteriological quality of drinking water from dispensers (coolers) and possible control measures. J Food Prot 69, 3043-3046. (Pubitemid 44954424)
3. Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R. & other authors (2001). Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183, 444-452.
4. Costerton, J. W., Cheng, K. J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M. & Marrie, T. J. (1987). Bacterial biofilms in nature and disease. Annu Rev Microbiol 41, 435-464.
5. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. (Pubitemid 29289651)
6. Drenkard, E. & Ausubel, F. M. (2002). Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416, 740-743. (Pubitemid 34429150)
7. Elkington, P. T., O'Kane, C. M. & Friedland, J. S. (2005). The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142, 12-20. (Pubitemid 41361000)
8. Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B. & Gibson, R. L. (2002). Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34, 91-100. (Pubitemid 34809519)
9. Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M. & Miller, S. I. (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565.
10. Frederiksen, B., Pressler, T., Hansen, A., Koch, C. & Hoiby, N. (2006). Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr 95, 1070-1074. (Pubitemid 44385111)
11. Gibson, R. L., Burns, J. L. & Ramsey, B. W. (2003). Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168, 918-951. (Pubitemid 37267172)
12. Gillis, R. J. & Iglewski, B. H. (2004). Azithromycin retards Pseudomonas aeruginosa biofilm formation. J ClinMicrobiol 42, 5842-5845. (Pubitemid 39664375)
13. Haslett, C., Guthrie, L. A., Kopaniak, M. M., Johnston, R. B., Jr & Henson, P. M. (1985). Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119, 101-110. (Pubitemid 15088729)
14. Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M. & Parsek, M. R. (2001). Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183, 5395-5401. (Pubitemid 32802613)
15. -/- mice. Antimicrob Agents Chemother 51, 3677-3687.
16. Hoyle, B. D. & Costerton, J. W. (1991). Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 37, 91-105.
17. Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J. & Riches, D. W. (1995). Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151, 1075-1082.
18. Khan, N. H., Ishii, Y., Kimata-Kino, N., Esaki, H., Nishino, T., Nishimura, M. & Kogure, K. (2007). Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb Ecol 53, 173-186. (Pubitemid 46317986)
19. Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes-Jorgensen, A., Molin, S. & Tolker-Nielsen, T. (2003). Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48, 1511-1524. (Pubitemid 36751058)
20. Lethem, M. I., James, S. L., Marriott, C. & Burke, J. F. (1990). The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 3, 19-23. (Pubitemid 20046657)
21. Moskowitz, S. M., Foster, J. M., Emerson, J. & Burns, J. L. (2004). Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42, 1915-1922. (Pubitemid 38637802)
22. Ogle, J. W., Janda, J. M., Woods, D. E. & Vasil, M. L. (1987). Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis 155, 119-126. (Pubitemid 17225092)
23. Onteniente, L., Brisse, S., Tassios, P. T. & Vergnaud, G. (2003). Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol 41, 4991-4997. (Pubitemid 37429907)
24. Parad, R. B., Gerard, C. J., Zurakowski, D., Nichols, D. P. & Pier, G. B. (1999). Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun 67, 4744-4750. (Pubitemid 29400459)
25. Perks, B. & Shute, J. K. (2000). DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics. Am J Respir Crit Care Med 162, 1767-1772. (Pubitemid 30947557)
26. Prosser, B. L., Taylor, D., Dix, B. A. & Cleeland, R. (1987). Method of evaluating effects of antibiotics on bacterial biofilm. Antimicrob Agents Chemother 31, 1502-1506. (Pubitemid 17140801)
27. Robinson, P. J. (2002). Dornase alfa in early cystic fibrosis lung disease. Pediatr Pulmonol 34, 237-241. (Pubitemid 34971080)
28. Roghanian, A., Drost, E. M., MacNee, W., Howie, S. E. & Sallenave, J. M. (2006). Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am J Respir Crit Care Med 174, 1189-1198. (Pubitemid 44924819)
29. Roum, J. H., Buhl, R., McElvaney, N. G., Borok, Z. & Crystal, R. G. (1993). Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 75, 2419-2424. (Pubitemid 24008354)
30. Rubin, B. K. (2007). Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 8, 4-7. (Pubitemid 46523785)
31. Schaedel, C., de Monestrol, I., Hjelte, L., Johannesson, M., Kornfalt, R., Lindblad, A., Strandvik, B., Wahlgren, L. & Holmberg, L. (2002). Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 33, 483-491. (Pubitemid 34547870)
32. Sheils, C. A., Kas, J., Travassos, W., Allen, P. G., Janmey, P. A., Wohl, M. E. & Stossel, T. P. (1996). Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 148, 919-927. (Pubitemid 126660683)
33. Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764. (Pubitemid 30780736)
34. Spencer, D. H., Kas, A., Smith, E. E., Raymond, C. K., Sims, E. H., Hastings, M., Burns, J. L., Kaul, R. & Olson, M. V. (2003). Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 185, 1316-1325. (Pubitemid 36176864)
35. Sriramulu, D. D., Lünsdorf, H., Lam, J. S. & Römling, U. (2005). Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54, 667-676. (Pubitemid 40885151)
36. Tang, J. X. & Janmey, P. A. (1996). The polyelectrolyte nature of F-actin and the mechanism of actin bundle formation. J Biol Chem 271, 8556-8563. (Pubitemid 26123271)
37. Tang, J. X., Wen, Q., Bennett, A., Kim, B., Sheils, C. A., Bucki, R. & Janmey, P. A. (2005). Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 289, L599-L605. (Pubitemid 41361670)
38. van Schaik, E. J., Giltner, C. L., Audette, G. F., Keizer, D. W., Bautista, D. L., Slupsky, C. M., Sykes, B. D. & Irvin, R. T. (2005). DNA binding: a novel function of Pseudomonas aeruginosa type IV pili. J Bacteriol 187, 1455-1464. (Pubitemid 40299469)
39. Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L. & Nick, J. A. (2005). Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73, 3693-3701. (Pubitemid 40745914)
40. Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. (2002). Extracellular DNA required for bacterial biofilm formation. Science 295, 1487. (Pubitemid 34173996)
41. 2 integrin clustering or activation in the control of apoptosis via regulation of Akt and ERK survival mechanisms. J Cell Biol 151, 1305-1320.